Loading...
Omnicell, Inc.
OMCL•NASDAQ
Healthcare
Medical - Healthcare Information Services
$29.76
$-1.25(-4.03%)
Omnicell, Inc. (OMCL) Financial Performance & Income Statement Overview
Review Omnicell, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-3.04%
↓ 3.04%
Operating Income Growth
100.97%
↑ 100.97%
Net Income Growth
161.51%
↑ 161.51%
Operating Cash Flow Growth
3.66%
↑ 3.66%
Operating Margin
1.34%
↑ 1.34%
Gross Margin
43.73%
↑ 43.73%
Net Profit Margin
2.008%
↑ 2.008%
ROE
1.85%
↑ 1.85%
ROIC
1.00%
↑ 1.00%
Omnicell, Inc. (OMCL) Income Statement & Financial Overview
Review Omnicell, Inc.'s (OMCL) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $399.004M | $386.83M | $369.20M | $570.63M |
| Short Term Investments | $0.00 | $12.60M | $12.47M | $11.70M |
| Cash & Short Term Investments | $399.004M | $399.43M | $381.68M | $582.33M |
| Net Receivables | $232.68M | $251.60M | $256.40M | $251.76M |
| Inventory | $105.78M | $91.14M | $88.66M | $95.06M |
| Other Current Assets | $107.31M | $97.50M | $88.76M | $82.11M |
| Total Current Assets | $844.78M | $839.67M | $815.49M | $1.01B |
| Property Plant & Equipment (Net) | $147.21M | $145.08M | $138.30M | $137.06M |
| Goodwill | $738.49M | $735.96M | $734.73M | $737.17M |
| Intangible Assets | $177.35M | $240.09M | $246.70M | $193.97M |
| Goodwill & Intangible Assets | $915.84M | $976.04M | $981.43M | $931.14M |
| Long Term Investments | $0.00 | $52.53M | $52.74M | $50.58M |
| Tax Assets | $59.80M | $61.36M | $57.47M | $42.09M |
| Other Non-Current Assets | $177.87M | $76.78M | $75.53M | $131.46M |
| Total Non-Current Assets | $1.30B | $1.31B | $1.31B | $1.29B |
| Total Assets | $2.15B | $2.15B | $2.12B | $2.30B |
| Account Payables | $62.41M | $53.27M | $51.78M | $47.81M |
| Short Term Debt | $0.00 | $186.11M | $185.03M | $582.61M |
| Tax Payables | $0.00 | $12.90M | $11.44M | $2.84M |
| Deferred Revenue | $153.60M | $225.06M | $201.98M | $152.37M |
| Other Current Liabilities | $315.97M | $130.20M | $330.48M | $175.89M |
| Total Current Liabilities | $594.39M | $607.53M | $595.68M | $961.52M |
| Long Term Debt | $372.56M | $199.72M | $197.52M | $31.52M |
| Deferred Revenue Non-Current | $0.00 | $78.37M | $0.00 | $69.81M |
| Deferred Tax Liabilities Non-Current | $1.31M | $1.17M | $1.11M | $1.41M |
| Other Non-Current Liabilities | $0.00 | $7.58M | $7.22M | $8.00M |
| Total Non-Current Liabilities | $373.87M | $286.84M | $281.97M | $110.74M |
| Capital Lease Obligations | $30.76M | $44.56M | $41.83M | $42.14M |
| Total Liabilities | $881.88M | $894.37M | $877.65M | $1.07B |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $0.00 | $57000.00 | $57000.00 | $57000.00 |
| Retained Earnings | $0.00 | $375.87M | $382.89M | $367.05M |
| Accumulated Other Comprehensive Income/Loss | $0.00 | -$13.81M | -$17.20M | -$10.30M |
| Total Stockholders Equity | $1.26B | $1.26B | $1.24B | $1.23B |
| Total Equity | $1.26B | $1.26B | $1.24B | $1.23B |
| Total Liabilities & Stockholders Equity | $2.15B | $2.15B | $2.12B | $2.30B |
| Total Investments | $0.00 | $65.14M | $65.22M | $62.27M |
| Total Debt | $372.56M | $385.83M | $382.55M | $614.14M |
| Net Debt | -$26.45M | -$999000.00 | $13.35M | $43.51M |
Omnicell, Inc. (OMCL) Balance Sheet Analysis
Omnicell, Inc. (OMCL) manages its money wisely, with plenty of 3.66% and 161.51% to cover its bills. The company’s long-term debts are manageable, balanced by steady 2.008%. Shareholders’ stake in the business has grown thanks to smart decisions. Overall, the numbers show a solid position, giving it room to invest, expand, or adapt. For investors, this paints a promising picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan